Roche Taps Compugen to Seek Non-SNP Markers for Drug Response

Dec 21, 2007

NEW YORK (GenomeWeb News) – Compugen and Roche have agreed to collaborate in an effort to search for biomarkers that could help predict patient responses to drugs aimed at treating rheumatoid arthritis, Compugen said Thursday.

Compugen will use its GeneVa database, which holds around 200,000 non-SNP genetic variations, to investigate DNA samples for markers that could predict response or non-response to selected drugs Roche intends to develop.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Corn's Complex Path

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

This Week in PLOS

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.

Five and Gone

CNBC reports that half of academic researchers leave after about five years.

From Within the Swamp

Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.

Main menu